SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS ARTICLE L impact

Cramer praises Smithfield, Eton and IES, pans BW

On CNBC’s Mad Money Lightning Round, Jim Cramer called Smithfield Foods inexpensive, said Eton Pharmaceuticals has been a winner and backed IES Holdings, while criticizing Babcock & Wilcox.

SFDBWETONIESC

On CNBC’s “ Mad Money Lightning Round,” Jim Cramer called packaged meat company Smithfield Foods (NYSE: SFD ) a “very inexpensive” stock. “I am willing to bet that at 8 times earnings you’re not going to lose money,” Cramer said. “And you could make some money with a 5.6% yield.” Smithfield Foods, on Aug.

11, posted record second-quarter adjusted operating profit of $300 million and first-half record of $638 million, up 2% year-over-year.

Cramer also covered: Babcock & Wilcox Enterprises, Inc. (NYSE: BW ).

The energy equipment maker is “ losing so much money.” On Aug.

10, the company reported second-quarter revenue of $319.7 million, a 130% increase.

Net Income was $14.3 million.

BillionToOne, Inc. (NASDAQ: BLLN ). “We decided it’s a pretty darn good company,” Cramer said when asked about the molecular diagnostics company. “I think you have a good one.” On the earnings front, BillionToOne, on Aug.

5, reported mixed third-quarter financial results and affirmed FY2026 sales guidance.

Eton Pharmaceuticals, Inc. (NASDAQ: ETON ).

It’s a “biotech that’s been a winner,” Cramer said. “I like to take a little bit off of the biotech winner and then let the rest run,” he added.

Eton Pharmaceuticals, on Aug.

13, reported better-than-expected second-quarter financial results and issued FY26 revenue guidance above estimates.

QXO, Inc. (NYSE: QXO ).

Cramer recommended buying this stock, which “goes from $14 to $24.

That’s why I think you should own it.” As per the recent news, QXO, on Monday, appointed Ken West as president and chief operating officer.

IES Holdings, Inc. (NASDAQ: IESC ).

Cramer considers it a “very interesting data communications company,” bit it has been brought down. “I don’t think that makes sense,” Cramer said. “I think you have a good one.” IES Holdings, on Aug.

10, agreed to acquire DBM Global from INNOVATE for cash and stock consideration valued at $650 million.

Price Action BillionToOne shares dipped 3.9% to settle at $96.22 on Wednesday.

Eton Pharmaceuticals shares fell 0.7% to close at $62.62 during the session.

Babcock & Wilcox fell 3.8% to settle at $7.53 on Wednesday.

Smithfield Foods shares slipped 0.9% to close at $22.06.

QXO shares gained 1.2% to settle at $14.02 on Wednesday.

IES shares climbed 5.8% to settle at $331.48 on Wednesday.

Read Also: Stock Market Today: S&P 500, Nasdaq 100 Futures Gain, While Dow Slips Following NVDA Blockbuster Q2 Report Photo via Shutterstock